Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Heliyon ; 7(3): e06143, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33748445

ABSTRACT

This work is concerned with the numerical study of laminar, steady MHD mixed convection flow, and entropy generation analysis of A l 2 O 3 -water nanofluid flowing in a lid-driven trapezoidal enclosure. The aspect ratio of the cavity is taken very small. The cavity is differentially heated to study the fluid flow, heat, and mass transfer rate. The adiabatic upper wall of the enclosure is allowed to move with a constant velocity along the positive x-direction. The second-order finite difference approximation is employed to discretize the governing partial differential equations, and a stream-function velocity formulation is used to solve the coupled non-linear partial differential equations numerically. The simulated results are plotted graphically through streamlines, isotherms, entropy generation, Nusselt number, and Sherwood number. The computations indicate that the average Nusselt number and average Sherwood number are decreasing functions of Hartmann number, aspect ratio, and nanoparticle volume fraction. Significant changes in streamlines, temperature and concentration contours for high Richardson number are observed.

2.
BMC Nephrol ; 21(1): 520, 2020 11 30.
Article in English | MEDLINE | ID: mdl-33256621

ABSTRACT

BACKGROUND: Approximately 30% of children with idiopathic nephrotic syndrome develop a complicated course with frequent relapses or steroid dependency. Rituximab, a B cell depleting monoclonal antibody, is a safe and effective alternative to steroids or other immunosuppressants for achieving and maintaining remission in this population at short term. Despite the good initial response relapses inevitably occur after regeneration of B lymphocytes, necessitating either repeat courses of rituximab or addition of another steroid-sparing immunosuppressant. METHODS: This is a prospective, single-center, open-label, two-parallel-arm randomized controlled phase III study among children with steroid dependent nephrotic syndrome who are maintained in remission with oral steroids. One hundred children will be randomized to either Rituximab and maintenance Mycophenolate mofetil (A) or repeated courses of prophylactic Rituximab only (B). In arm A, mycophenolate mofetil (1200 mg/m2 per day) will be started 3 months after Rituximab administration. In arm B, Rituximab infusions will be administered at 0, 8 and 16 months if B cell count normalize at the given time points. Prednisolone will be discontinued in both groups 2 weeks following first course of rituximab. Primary aim is to evaluate the difference in 24-month relapse-free survival. Main secondary endpoints are cumulative prednisolone dose, frequency of relapses and changes in anthropometry. Circulating B lymphocyte populations will be studied as biomarkers or predictors of rituximab responsiveness and adverse events will be analysed. DISCUSSION: The study will provide evidence as to the comparative safety and efficacy of two alternative steroid-sparing therapeutic options in children suffering from steroid dependent nephrotic syndrome. The two-year study design will address the long-term results obtained with the alternative treatment protocols. TRIAL REGISTRATION: This trial was prospectively registered to the Clinicaltrial.gov ( NCT03899103 dated 02/04/2019; https://clinicaltrials.gov/ ) and Clinical Trials Registry of India ( CTRI/2019/04/018517 dated 09/04/2019).


Subject(s)
Glucocorticoids/therapeutic use , Immunologic Factors/therapeutic use , Mycophenolic Acid/therapeutic use , Nephrotic Syndrome/drug therapy , Rituximab/administration & dosage , Adolescent , Child , Child, Preschool , Clinical Trials, Phase III as Topic , Female , Humans , Maintenance Chemotherapy , Male , Randomized Controlled Trials as Topic , Remission Induction , Treatment Outcome
3.
Public Health ; 179: 68-75, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31733509

ABSTRACT

OBJECTIVES: For population-level screening of malnutrition among adults-especially in developing-country settings-the body mass index (BMI) can be impractical because of logistical requirements for weight and height measurement. We analyzed anthropometric data collected from a large-scale nutritional survey on women of rural Bihar to determine the mid-upper arm circumference (MUAC) cutoffs corresponding to standard BMI cutoffs and the predictive accuracies of the determined cutoffs. STUDY DESIGN: It was a cross-sectional study using multistage cluster sampling. METHODS: The current analysis used anthropometric data from a study on dietary practices of rural women (adolescents, lactating mothers, and women in the interpregnancy period). The MUAC (cm) cutoffs corresponding to four standard BMI (kg/m2) values were determined using receiver operating characteristic (ROC) curve analysis. RESULT: We detected a significant positive correlation between BMI and MUAC (r = 0.81, P < 0.0001). In ROC curve analysis, the MUAC cutoffs corresponding to BMI cutoffs of 18.5, 23, 25, and 30 kg/m2 were estimated to be 23.2, 26.0, 27.3, and 30.5 kg/m2, respectively. The predictive accuracy of the determined cutoffs was good, as indicated by the area under the ROC curve for the four different cutoffs-which ranged between 88% and 97%. Other than the cutoff for 'obese' (BMI, 30 kg/m2), the Kappa coefficients for the rest of the MUAC cutoffs showed 'substantial' agreement (>0.6) with their BMI counterparts. CONCLUSION: The results suggest that the cutoffs based on MUAC-a less resource-intensive measure than BMI-can be used for community-based screening of malnutrition among women of Bihar.


Subject(s)
Anthropometry/methods , Arm/anatomy & histology , Asian People/statistics & numerical data , Nutritional Status , Adolescent , Adult , Arm/physiology , Body Mass Index , Body Weight , Cross-Sectional Studies , Female , Humans , India , Male , Middle Aged , Obesity , Rural Population , Sensitivity and Specificity
4.
Heliyon ; 5(9): e02496, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31687588

ABSTRACT

A numerical investigation of entropy generation, heat and mass transfer is performed on steady double diffusive natural convection of water-based Al2O3 nanofluid within a wavy-walled cavity with a center heater under the influence of an uniform vertical magnetic field. The top horizontal wavy wall, left and right vertical walls of the enclosure are kept at low temperature and concentration of T c and c c whereas central part of the bottom horizontal wall is maintained at high temperature and concentration of T h and c h and the remaining part is kept adiabatic where temperature and concentration gradient are taken as zero. The Bi-CGStab method and Tri-diagonal algorithm are used to solve the governing equations. The study has been performed for several relevant parameters such as Rayleigh number ( 10 3 ≤ R a ≤ 10 5 ), Hartmann number ( 0 ≤ H a ≤ 60 ), buoyancy ratio number ( - 2 ≤ N ≤ 2 ), volume fraction of nanoparticles ( 0.0 ≤ ϕ ≤ 0.2 ) and different undulation number of the upper wavy wall (n). The Prandtl number and Lewis number are kept fixed at Pr = 6.2 and Le = 2 . The effect of these parameters are revealed in terms of streamlines, isotherms, isoconcentrations, entropy generation, average Nusselt number and Sherwood number. Results indicate that heat and mass transfer rate augment as Rayleigh number and volume fraction of nanoparticles increase and are found to drop with the increase in Hartmann number and buoyancy ratio.

5.
JAMA Pediatr ; 172(8): 757-764, 2018 08 01.
Article in English | MEDLINE | ID: mdl-29913001

ABSTRACT

Importance: Calcineurin inhibitors are an established first-line corticosteroid-sparing therapy for patients with corticosteroid-dependent nephrotic syndrome (CDNS), whereas B-lymphocyte-depleting therapy is mostly used as a rescue for calcineurin inhibitor-resistant cases. The positive efficacy and safety profile of rituximab raises the question of whether it could be used as a first-line alternative to calcineurin inhibitor therapy. Objective: To compare the efficacy of rituximab and tacrolimus in maintaining relapse-free survival among children with CDNS. Design, Setting, and Participants: A parallel-arm, open-label, randomized clinical trial was performed from May 8, 2015, to September 20, 2016, with 1-year follow-up in a single-center, tertiary care unit. A total of 176 consecutive children aged 3 to 16 years with CDNS not previously treated with corticosteroid-sparing agents were screened for eligibility. Interventions: The children received either tacrolimus (along with tapering alternate-day prednisolone) for 12 months or a single course of rituximab (2 infusions of 375 mg/m2). Main Outcomes and Measures: Twelve-month relapse-free survival in the intention-to-treat population. Results: Of the 176 children screened for eligibility, 120 were randomized and all but 3 patients completed 1 year of follow-up. The groups were comparable, with mean (SD) age of 7.2 (2.8) years, 32 boys (53.3%) in each group, mean (SD) disease duration of 2.5 (1.5) years and 2.3 (1.7) in the tacrolimus and rituximab groups, respectively, disease duration less than 1 year among 15 children (25.0%) in each group, median (interquartile range) of 4 (3-5) relapses in each group, and mean (SD) cumulative prednisolone dose of 246 (48) mg/kg and 239 (52) mg/kg in the prestudy year in the tacrolimus and rituximab groups, respectively. Rituximab therapy was associated with a higher 12-month relapse-free survival rate than tacrolimus (54 [90.0%] vs 38 [63.3%] children; P < .001; odds ratio, 5.21; 95% CI, 1.93-14.07). Among the patients who experienced relapse, median time to first relapse was 40 weeks in the rituximab group and 29 weeks in the tacrolimus group. Only 2 patients in the rituximab group had more than 1 relapse during the study period compared with 10 patients in the tacrolimus group. The cumulative corticosteroid dose during the 12-month study period was lower with rituximab compared with tacrolimus (mean [SD], 25.8 [27.8] vs 86.3 [58.0] mg/kg). Although both treatments were well tolerated, mild to moderate infections were twice as common in the tacrolimus group (26 [43.3%] vs 13 [21.7%] events). Conclusions and Relevance: In children with CDNS, rituximab appears to be more effective than tacrolimus in maintaining disease remission and minimizing corticosteroid exposure and, given its good tolerability and lack of nephrotoxic effects, may be considered as first-line corticosteroid-sparing therapy. Trial Registration: ClinicalTrials.gov Identifier: NCT02438982; Clinical Trial Registry of India: CTRI/2014/01/004355.


Subject(s)
Nephrotic Syndrome/drug therapy , Rituximab/therapeutic use , Tacrolimus/therapeutic use , Child , Disease-Free Survival , Female , Glucocorticoids/therapeutic use , Humans , Male , Prednisolone/therapeutic use , Treatment Outcome
6.
Clin Exp Nephrol ; 21(1): 143-151, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27108294

ABSTRACT

BACKGROUND: Calcineurin inhibitors (CNI), mycophenolate mofetil (MMF), and levamisole are common treatment choices for patients with frequently relapsing (FRNS) and steroid-dependent nephrotic syndrome (SDNS). METHODS: In this retrospective cohort study, we analyzed the relative efficacy and safety of tacrolimus, MMF, and levamisole over a period of 30 months, in treating 340 children with idiopathic FRNS/SDNS. The children received either MMF 1200 mg/m2 daily, or levamisole 2.5 mg/kg on alternate days, or tacrolimus 0.1-0.2 mg/kg daily along with tapering doses of alternate-day prednisolone. RESULTS: Tacrolimus was associated with a higher rate of 30-month relapse-free survival when compared to MMF (61.7 vs. 38.5 %, p < 0.001), or levamisole (61.7 vs. 24 %, p < 0.001). However, relapse rate increased almost threefold once tacrolimus was stopped, resulting in a higher relapse rate per patient-year when compared to the MMF group (2.0 vs. 1.5, p = 0.013). The cumulative prednisolone dose per patient during the last year of the study period was also increased among tacrolimus group in comparison with MMF group (96.4 vs. 74.4 mg/kg/year, p = 0.004). Independent of the impact of drug choice, the relapse risk was higher in patients with steroid dependency at baseline (HR 2.14, 95 %CI 1.79-2.96, p < 0.0001). In comparison with few minor adverse events in other two cohorts, several serious adverse events were documented in the tacrolimus group. CONCLUSIONS: Although there are serious safety concerns regarding tacrolimus, it is more effective than MMF or levamisole in maintaining relapse-free survival. However, unlike MMF, the relative efficacy of tacrolimus in preventing further relapses is seen only when the patient is on the drug. Taking together the long-term efficacy and safety data observed, MMF appears as a safe and effective alternative to tacrolimus in managing pediatric FRNS/SDNS.


Subject(s)
Calcineurin Inhibitors/administration & dosage , Glucocorticoids/administration & dosage , Immunosuppressive Agents/administration & dosage , Levamisole/administration & dosage , Mycophenolic Acid/administration & dosage , Nephrotic Syndrome/therapy , Prednisolone/administration & dosage , Tacrolimus/administration & dosage , Adolescent , Calcineurin Inhibitors/adverse effects , Child , Child, Preschool , Disease-Free Survival , Drug Administration Schedule , Female , Glucocorticoids/adverse effects , Humans , Immunosuppressive Agents/adverse effects , Infant , Levamisole/adverse effects , Male , Mycophenolic Acid/adverse effects , Nephrotic Syndrome/diagnosis , Prednisolone/adverse effects , Recurrence , Retrospective Studies , Tacrolimus/adverse effects , Time Factors , Treatment Outcome
7.
J Hum Hypertens ; 31(1): 56-65, 2017 01.
Article in English | MEDLINE | ID: mdl-27193382

ABSTRACT

Early detection is the cornerstone of hypertension management; still majority remains undetected until complications arise, especially in poor-resource settings. Paucity of information regarding undiagnosed and uncontrolled hypertension in eastern India thus called for a detailed investigation involving a representative sample of adults in Malda, one of the poorest districts in the region. In a cross-sectional study, between October 2013 and July 2014, using multistage random sampling with probability-proportional-to-size, 18 028 consenting adults were interviewed. Diagnosed cases were defined as uncontrolled if they still had hypertensive level of blood pressure (according to JNC-VIII criteria) while those detected during this study were defined as undiagnosed. Descriptive and regression analyses were performed using SAS version 9.3.2. Among 18 028 participants, 4695 (26.04% (95% confidence intervals: 95% CI=25.40-26.68)) had hypertension, of which 3937 (83.86% (82.80-84.91)) were undiagnosed and 548 (72.30 (69.10-75.49)) had uncontrolled hypertension. Relatively older subjects (adjusted Odds ratio (aOR)41-60 years=0.34 (95% CI=0.26-0.43) and aOR>60 years=0.29 (0.21-0.38)), who were divorced/separated/widowed/widower (aOR=0.76 (0.61-0.95)), had higher education (aOR=0.61 (0.43-0.88)), better socio-economic status (SES) (aORMiddle=0.77 (0.60-0.99) and aORUpper=0.64 (0.48-0.85)) and urban residence (aOR=0.44 (0.36-0.55)) were less likely while subjects who belonged to backward castes (aOR=1.37 (1.15-1.64)) were more likely to have undiagnosed hypertension. Odds of having uncontrolled hypertension were higher among participants aged >60 years (aOR=2.25 (1.27-3.99)). Burden of hypertension (diagnosed and undiagnosed) was high in Malda district of West Bengal. Significant predictors of undiagnosed hypertension were young age, backward caste, poor education and lower SES, while older subjects had poor control. Thus, appropriate surveillance targeting these at-risk groups might be effective in controlling hypertension in similar poor-resource settings.


Subject(s)
Developing Countries/statistics & numerical data , Hypertension/epidemiology , Adolescent , Adult , Cost of Illness , Cross-Sectional Studies , Female , Humans , Hypertension/diagnosis , Hypertension/therapy , India/epidemiology , Male , Middle Aged , Socioeconomic Factors , Young Adult
8.
HIV Med ; 18(3): 141-150, 2017 03.
Article in English | MEDLINE | ID: mdl-27552922

ABSTRACT

OBJECTIVES: Despite a recent increase in the HIV/AIDS epidemic among young people in China, youth-specific HIV data are limited. METHODS: In total, 56 621 individuals with HIV/AIDS, aged 15-24 years, registered in the Case Reporting System of China between 2005 and 2012 and having complete spatial information were included in the present analysis. Spatial autocorrelation (general and local) and space-time scanning were performed using the ArcGIS 10.2 and SaTScan 9.3 software, respectively. RESULTS: During 2005-2012, the number of reported HIV/AIDS cases and the proportion of HIV cases increased while the proportion of AIDS cases decreased. Sexual contact became the predominant route of transmission in later years. Spatial analysis showed marked geographical variations in HIV infection among young people throughout China during 2005-2012. The number of new hotspots increased over time. They were mainly localized to southeastern coastal areas, southwestern frontier provinces or autonomous regions (of Guangxi, Yunnan and Sichuan) and Beijing municipality. Later these hotspots disappeared and new hotspots were found in the northeast of the country. Significant clusters of HIV-positive cases were identified in three different time periods, which indicated high HIV transmission among young Chinese people in the recent past. The risk of HIV infection was highest in the first cluster (2009-2012; this cluster was the largest in size) covering the provinces of Guizhou and Yunnan, the Chongqing municipality, Guangxi, and the province of Sichuan. The second cluster (2010-2012) was mostly located in Shanghai, South Jiangsu, Zhejiang and South Anhui, while the third cluster (2010-2012) was located in Beijing and Tianjin. CONCLUSIONS: Target-specific comprehensive behavioural interventions are urgently needed to contain the HIV epidemic among young people.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Epidemics , Topography, Medical , Adolescent , China/epidemiology , Female , Humans , Male , Spatio-Temporal Analysis , Young Adult
9.
Pediatrics ; 136(1): e132-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26101364

ABSTRACT

BACKGROUND: Rituximab is being increasingly used in children with idiopathic nephrotic syndrome resistant to standard treatments. In spite of good initial response, rituximab responders always remain prone to further relapse, necessitating either repeat course of rituximab or addition of another steroid-sparing immunosuppressant. METHODS: A retrospective analysis of baseline clinico-pathologic presentation and treatment outcome (complete remission, partial remission, or no response) was performed among 24 children with refractory-idiopathic SRNS over a follow-up period of 24 months. Children received 2 to 4 rituximab infusions (375 mg/m(2) weekly) depending on circulating B-cell level. At 3-month follow-up, a second course of rituximab was administered (if >5 B cells/mm(3)) along with MMF (1200 mg/m(2) per day) maintenance therapy. RESULTS: Of 24 patients, 54% (13/24) and 46% (11/24) had minimal change disease and focal segmental glomerulosclerosis, respectively, on renal histopathology. After the first course of rituximab, 21% (5/24) of children achieved complete remission; however, most (4/5) of them relapsed again at a median interval of 53 (interquartile range 46-72) days. Depending on response to the first course of rituximab, MMF was started on 15 children at 3 months. After 6 months, 67% (10/15) of children on MMF achieved complete remission and 33% (5/15) remained at partial remission. At 24 months overall, 25% (6/24) and 42% (10/24) of children were in complete remission and partial remission, respectively; 33% (5/15) of children continued sustained complete remission after postrituximab-MMF maintenance therapy in comparison with no sustained complete remission with rituximab alone at 24 months (P < .001). CONCLUSIONS: MMF may be an effective and safe maintenance therapy to consider as an additive immunosuppressant after induction with rituximab in maintaining remission among children with refractory SRNS.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/administration & dosage , Mycophenolic Acid/analogs & derivatives , Nephrotic Syndrome/congenital , Adolescent , Anti-Inflammatory Agents, Non-Steroidal , Antigens, CD20 , Child , Child, Preschool , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Immunologic Factors/administration & dosage , Immunosuppressive Agents/administration & dosage , Male , Mycophenolic Acid/administration & dosage , Nephrotic Syndrome/drug therapy , Remission Induction , Retrospective Studies , Rituximab , Time Factors , Treatment Outcome
10.
Am J Kidney Dis ; 2015 Jun 09.
Article in English | MEDLINE | ID: mdl-26071057

ABSTRACT

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

11.
Nephrol Dial Transplant ; 30 Suppl 1: i113-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25758433

ABSTRACT

BACKGROUND: Microscopic polyangiitis (MPA) is one of the most common forms of antineutrophil cytoplasm autoantibodies (ANCA)-associated vasculitis in children. Cyclophospamide and glucocorticoid-based treatment protocols are still considered gold standard in managing this multi-system disorder. But treatment-related toxicity is a major cause of chronic morbidity and early mortality in MPA. Hence, the search for an effective and safe alternative immunosuppressant is essential. METHODS: A retrospective analysis of baseline clinico-pathological presentation and treatment-outcome was performed among 11 paediatric MPA patients. All of whom were treated with a pre-specified cyclophosphamide free, rituximab- and mycophenolate mofetil (MMF)-based management protocol as per centre practice. RESULTS: We describe the clinical course of 11 children with MPA over a median follow-up period of 20.9 months. Both patient survival and renal survival at 1 year follow-up were 100%. In spite of the varying degree of renal involvement at presentation, kidney function was recovered in all patients with a median estimated glomerular filtration rate (eGFR) of 79.5 mL/min/1.73 m(2). At last follow-up, 91% (10/11) of patients were in complete remission and one (9%) child continued partial remission state. There was no treatment failure. In total, 73% (8/11) of patients were off steroids at last follow-up and 82% (9/11) of patients never relapsed during follow-up period. CONCLUSIONS: Efficacy and medium-term safety of rituximab- and MMF-based protocol in managing children with MPA was evident in this study.


Subject(s)
Algorithms , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Kidney Diseases/prevention & control , Microscopic Polyangiitis/mortality , Mycophenolic Acid/analogs & derivatives , Antibodies, Antineutrophil Cytoplasmic/immunology , Antineoplastic Agents/therapeutic use , Child , Child, Preschool , Drug Therapy, Combination , Female , Follow-Up Studies , Glomerular Filtration Rate , Humans , Immunosuppressive Agents/therapeutic use , Kidney Diseases/mortality , Male , Microscopic Polyangiitis/drug therapy , Microscopic Polyangiitis/pathology , Mycophenolic Acid/therapeutic use , Remission Induction , Retrospective Studies , Rituximab , Survival Rate , Treatment Outcome
12.
Pediatr Pulmonol ; 50(3): 271-275, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24619925

ABSTRACT

OBJECTIVE: Prediction of mortality among newborns on mechanical ventilation is difficult. Our aim was to develop a scoring system for predicting mortality among such neonates. METHODS: This multi centre prospective study was performed to develop and validate a scoring system among two equal cohorts of ventilated newborns in India. Mechanical ventilator was used in pressure-limited time-cycled mode. Arterial blood gas, initial pulmonary pressures, septicemia screen along with other basic parameters were recorded in a pre-structured proforma. Blood samples were analyzed for malondialdehyde to determine the possible role and predictive validity of free radical injury. Multiple logistic regression analysis was done to find out independent predictors of mortality for the variables those were significantly associated with outcome after univariate analysis. RESULTS: On univariate analysis, birth-weight, oxygenation-index, septicaemia, malondialdehyde level, and inotropic support were significantly associated with mortality. However, after multiple regression analysis gestational-age, pH and FiO2 lost their significance as predictors. According to cut-off values of ROC-curve, a scoring system ranging from 0 to 20 and four mortality risk groups were developed. Area under ROC-curve was 0.94, compared to 0.90 for both APACHE-III and CRIB-scores; and 0.92 for PRISM-score. CONCLUSIONS: Birth-weight, oxygenation-index, malondialdehyde level, inotropic support, and septicemia are independent mortality predictors of neonatal ventilation. Increase in malondialdehyde level is associated with higher mortality rate, indicating possible role of free radical injury. Pediatr Pulmonol. 2015; 50:271-275. © 2014 Wiley Periodicals, Inc.

13.
Epidemiol Infect ; 142(2): 314-26, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23659645

ABSTRACT

Diarrhoeal management practices are unsatisfactory in India especially in the slum areas. Dearth of information regarding physicians' diarrhoea-related knowledge and practice in India necessitated this cross-sectional study of allopathic practitioners in the slums of Kolkata, to assess the distribution and interrelationship between physicians' characteristics, knowledge and practice regarding diarrhoea. A total of 264 randomly selected consenting practitioners were interviewed using a field-tested questionnaire. Nineteen percent had good overall knowledge, 49% and 80% prescribed antibiotics to diarrhoea and cholera patients, respectively, and 55% advised stool examination for every case. Qualified and Government physicians had better knowledge regarding diarrhoea [MBBS: odds ratio (OR) 5·96, P < 0·001; postgraduates: OR 9·33, P < 0·001; Government physicians: OR 11·49, P < 0·0001] and were less likely to prescribe antibiotics for all diarrhoea cases (MBBS: OR 0·30, P = 0·002; postgraduates: OR 0·20, P < 0·001; Government physicians OR 0·24, P < 0·029). Better knowledge was associated with a lower likelihood of prescribing antibiotics for diarrhoea (OR 0·72, P < 0·001), cholera (OR 0·78, P = 0·027) and investigative procedure (OR 0·85, P = 0·028). In the slums of Kolkata, diarrhoea-related knowledge and practice were poor with the exception of qualified physicians, hence an improvement in the knowledge of pharmacists and unqualified practitioners is necessary for the overall improvement of diarrhoeal management in these slums.


Subject(s)
Clinical Competence/statistics & numerical data , Diarrhea/therapy , Poverty Areas , Practice Patterns, Physicians'/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Clinical Competence/standards , Diarrhea/drug therapy , Diarrhea/prevention & control , Female , Humans , India/epidemiology , Interviews as Topic , Male , Practice Patterns, Physicians'/standards , Socioeconomic Factors , Surveys and Questionnaires , Urban Population/statistics & numerical data
14.
Oman J Ophthalmol ; 3(1): 23-5, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20606869

ABSTRACT

Ellis-van Creveld syndrome is a rare short-limbed disproportionate dwarfism characterized by postaxial polydactyly, several skeletal, oral mucosal and dental anomalies, nail dysplasia and in 50-60% cases of congenital cardiac defects. It is an autosomal recessive disorder with mutations of the EVC1 and EVC2 genes located on chromosome 4p16. Patients with this syndrome usually have a high mortality in early life due to cardiorespiratory problems. We present the case of a six- month-old female infant with Ellis-van Creveld syndrome - essential infantile esotropia, which has been infrequently documented in the literature.

15.
Breast ; 19(3): 202-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20347309

ABSTRACT

BACKGROUND: Autologous fat transplantation has been used to correct cosmetic deformities in almost all areas of the body. In recent years, there has been a resurgence of interest in the use of fatty tissue to fill defects resulting from breast conserving surgery (BCS) and asymmetries after reconstructive breast surgery. METHODS: A Medline database search was performed, and the published evidence was reviewed. RESULTS & CONCLUSION: We describe and discuss the technique and indications, advantages, disadvantages and future direction of fat transfer to the breast. SEARCH METHODOLOGY: A Medline database search was used to retrieve relevant literature. Key search words used were: breast fat transfer, fat auto-transplantation, adipose tissue injection and lipomodelling. As a number of original articles are in French these were translated and used in addition to the English publications.


Subject(s)
Adipose Tissue/transplantation , Breast Neoplasms/surgery , Mammaplasty/methods , Mastectomy , Breast Neoplasms/pathology , Female , Humans
16.
Eur J Surg Oncol ; 27(7): 617-20, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11669587

ABSTRACT

AIMS: This study aimed to examine the feasibility of utilizing dynamic contrast-enhanced MRI (DCE-MRI) of the breast for the planning of surgical intervention following neoadjuvant therapy for locally advanced breast cancer (LABC). METHODS: Following their neoadjuvant therapy, women with LABC were followed-up by DCE-MRI in addition to clinical examination and mammography. If any modality suggested residual disease, surgery was carried out--initially salvage mastectomy and then breast-conserving surgery where appropriate. RESULTS: Seventeen women were recruited: stage III (n=16), stage IV (n=1) mean age 55 (range 34-74). Following neoadjuvant therapy, 10 mastectomies and two local excisions were performed for 10 histologically confirmed residual cancers. Median follow-up for those women not undergoing surgery is 3.24 (IQR 2.8-3.5) years. DCE-MRI proved 100% accurate for the delineation of residual disease and facilitated the planning of the local excisions. Clinical examination and mammography proved inaccurate (PPV 83% and 75% and NPV 55% and 80%, respectively). CONCLUSIONS: DCE-MRI is a potentially accurate method of delineating residual tumour following neoadjuvant therapy for LABC and may be used to plan appropriate operative intervention where required.


Subject(s)
Breast Neoplasms/pathology , Magnetic Resonance Imaging/methods , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols , Breast Neoplasms/drug therapy , Female , Humans , Mastectomy , Middle Aged , Neoadjuvant Therapy , Neoplasm, Residual , Patient Selection , Sensitivity and Specificity
17.
Ann R Coll Surg Engl ; 82(6): 396-400, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11103156

ABSTRACT

INTRODUCTION: Inguinal hernia repair is the most common surgical procedure performed in the UK. Evidence from several earlier studies suggests that primary inguinal hernia repair has a high recurrence rate of 10-15%. The Royal College of Surgeons of England guidelines suggested the use of layered suture (Shouldice) or prosthetic (Lichtenstein) repair. Per-fix plugs have been used in the US for more than a decade with excellent results. This study was a series of 200 consecutive cases. The aim was to evaluate the mesh plug technique in the repair of all types of inguinal hernias and its results in one consultant practice within a district general hospital. PATIENTS AND METHODS: In a 15-month period between 1997 and 1998, all patients with inguinal hernias presenting to the general surgical clinic of one consultant were recruited to the study. All had mesh plug repair under local (n = 40), regional (n = 50) or general (n = 110) anaesthesia either by the consultant, associate specialist or specialist registrar (following initial training), using the same standard technique. The majority 80% (n = 160) were done as day cases. The results were evaluated by questionnaire and personal outpatient review initially at 3 weeks, then at 1 year (9-13 months). RESULTS: 200 consecutive patients with inguinal hernias underwent mesh plug repair; mean age was 54 years (95% CI, 46-61). The majority of patients had primary (n = 180) and others had recurrent (n = 20) hernia. All types of hernia (Gilbert's I-VII) were included. Median follow-up was 1 year (9-15 months). Groin pain, which was the leading symptom at presentation, was relieved in 96% of the patients; 79% returned to previous jobs within 4 weeks (95% CI, 0.71-0.87). All retired patients resumed normal life activities within 2 days. Postoperative pain was minimal; 28 patients did not require any postoperative analgesia. There were very few minor (n = 6) and no major complications. During the follow-up, one recurrence occurred. CONCLUSIONS: Mesh plug repair is associated with minimal postoperative pain, quick recovery and return to work. It is an ideal technique for day-case surgery. Although longer follow-up will be required to assess true recurrence rate, so far the recurrence rate at 0.5% is acceptable, particularly in the light of other published series.


Subject(s)
Hernia, Inguinal/surgery , Surgical Mesh , Adult , Aged , Aged, 80 and over , Ambulatory Surgical Procedures/methods , Digestive System Surgical Procedures/methods , Female , Follow-Up Studies , Hernia, Inguinal/rehabilitation , Humans , Length of Stay , Male , Middle Aged , Pain, Postoperative/drug therapy , Patient Satisfaction , Postoperative Complications , Prospective Studies , Recurrence
18.
J Trop Pediatr ; 46(5): 259-63, 2000 10.
Article in English | MEDLINE | ID: mdl-11077932

ABSTRACT

A double-blind, randomized, controlled clinical trial was conducted on 80 malnourished children with acute dehydrating diarrhoea to evaluate the efficacy of oral supplementation of zinc as an adjunct therapy to oral rehydration solution (ORS). After decoding it was observed that 44 children received zinc sulphate (177 mg/kg/day in three divided doses equivalent to 40 mg elemental zinc) in a syrup form and 36 children received only syrup placebo. Clinical parameters and microbiological findings of stool samples were comparable in the two groups at the time of enrollment. All the children (100 per cent) in the zinc supplemented group and 32 (89 per cent) children in the placebo group recovered within 5 days of hospitalization (p = 0.04). The zinc supplemented group had a significantly shorter duration of diarrhoea (70.4 +/- 10.0 vs. 103.4 +/- 17.1 h; p = 0.0001), passed less liquid stool (1.5 +/- 0.7 vs. 2.4 +/- 0.7kg; p=0.0001), consumed less oral rehydration solution (2.5 +/- 1.0 vs. 3.6 +/- 0.8 litre; p = 0.0001) and other liquids (867.0 +/- 466.1 vs. 1354.7 +/- 675.6 ml; p = 0.0001) as compared to the placebo group. Our findings suggest that zinc supplementation as an adjunct therapy to ORS has beneficial effects on the clinical course of dehydrating acute diarrhoea.


Subject(s)
Diarrhea, Infantile/complications , Diarrhea, Infantile/therapy , Dietary Supplements , Fluid Therapy/methods , Nutrition Disorders/complications , Zinc/administration & dosage , Acute Disease , Chi-Square Distribution , Dehydration/diagnosis , Dehydration/therapy , Diarrhea, Infantile/diagnosis , Double-Blind Method , Humans , Infant , Male , Nutrition Disorders/diagnosis , Prognosis , Reference Values , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...